A Retrospective Study on Therapeutic Efficacy of Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors Plus Lenvatinib in Patients With Unresectable Hepatocellular Carcinoma
Objective: We assessed the efficacy and safety of transarterial chemoembolization (TACE) in combination with lenvatinib plus programmed death receptor-1 (PD-1) signaling inhibitors (camrelizumab or sintilimab) in unresectable hepatocellular carcinoma (uHCC). Methods: In this retrospective study, pat...
Saved in:
| Main Authors: | , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | 英语 |
| 出版: |
2022
|
| 在線閱讀: | https://doi.org/10.1177/15330338221075174 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|